Patent · US Active

Alpha crystalline form of strontium ranelate

US7459568B2 · kind B2 · utility

2Cited by
0References
5Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 31, 2005
Grant dateDec 2, 2008
Priority date
Expiry dateSep 10, 2026

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P19/10
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Alpha crystalline form of strontium ranelate of formula (I):characterized by its powder X-ray diffraction diagram and by a water content of from 22 to 24%.Medicinal products containing the same which are useful in the treatment of osteoporosis and arthrosis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.